Endocrinology (all articles)
Crossover RCT | Preliminary study showed closed-loop insulin delivery might improve glycemic control in some adults with Type 2 DM
15 Jan, 2023 | 19:56h | UTCNews Release: Artificial pancreas successfully trialed for use by type 2 diabetes patients – University of Cambridge
Commentary: Artificial Pancreas Device May Help Folks With Type 2 Diabetes – HealthDay
Report | Obstacles and opportunities in managing coexisting obesity and CKD
13 Jan, 2023 | 13:30h | UTC
M-A | Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy effects on obesity comorbidities
12 Jan, 2023 | 13:00h | UTC
M-A | Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease
12 Jan, 2023 | 12:57h | UTC
M-A | The prevalence of obesity among children with type 2 DM
12 Jan, 2023 | 12:53h | UTCCommentary: Not All Pediatric Cases of Type 2 Diabetes Have Obesity – HealthDay
Commentary on Twitter
Meta-analysis finds that 75% of children with type 2 diabetes have obesity; not all pediatric T2DM patients have obesity. Further studies are needed to investigate the mechanisms beyond obesity driving this condition in children. https://t.co/RsDVSDq7rq
— JAMA Network Open (@JAMANetworkOpen) December 16, 2022
NICE Guideline | Thyroid cancer: assessment and management
11 Jan, 2023 | 14:34h | UTCThyroid cancer: assessment and management – National Institute for Health and Care Excellence
Guideline Synopsis | Diabetes management in chronic kidney disease
10 Jan, 2023 | 14:52h | UTCCommentary: Layered Approach Recommended for Patients With Diabetes, CKD – HealthDay
Original Guideline: KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease.
AAP Guideline | Evaluation and treatment of children and adolescents with obesity
10 Jan, 2023 | 14:54h | UTCExecutive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity – Pediatrics
Commentaries:
Childhood obesity requires early, aggressive treatment, new guidelines say – NPR
New guidance: Use drugs, surgery early for obesity in kids – Associated Press
Diagnostic accuracy study | Home waking salivary cortisone to screen for adrenal insufficiency
10 Jan, 2023 | 14:47h | UTCHome Waking Salivary Cortisone to Screen for Adrenal Insufficiency – NEJM Evidence
Commentary: At-home saliva test to diagnose adrenal insufficiency makes a difference to patients’ health – News Medical
Commentary on Twitter
This prospective study tested use of home waking salivary cortisone levels to predict adrenal insufficiency. Salivary cortisone had diagnostic accuracy similar to that of a standard adrenocorticotropin (ACTH) stimulation test. https://t.co/EYEBppBN7y#EndoTwitter #MedTwitter pic.twitter.com/RsKvnCHrUQ
— NEJM Evidence (@NEJMEvidence) January 6, 2023
Restoring mortality data in the FOURIER trial of evolocumab in patients with CVD: a reanalysis based on regulatory data
10 Jan, 2023 | 14:49h | UTCCommentaries:
Yet Another Story on Re-Analyzing a Major Trial – Sensible Medicine
Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees – TCTMD
Podcast | Endocrine emergencies
10 Jan, 2023 | 14:32h | UTC#372 Endocrine Emergencies featuring Dr. Sara Markley Webster – The Curbsiders
ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults
9 Jan, 2023 | 14:59h | UTCSummary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults
Guideline | Treatment of hypercalcemia of malignancy in adults
9 Jan, 2023 | 14:46h | UTCNews Release: Experts provide first framework for treating hypercalcemia of malignancy in adults – News Medical
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidemias
9 Jan, 2023 | 14:26h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Dyslipidaemia https://t.co/jpkqgt4Hf1 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #dyslipidemia pic.twitter.com/UBfKy45mAu
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets.
16 Dec, 2022 | 13:52h | UTCNews Release: WHO calls on countries to tax sugar-sweetened beverages to save lives – World Health Organization
Related:
M-A: Outcomes following taxation of sugar-sweetened beverages.
Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents – Pediatrics
Cutting back on sugar-sweetened beverages: What works? – Cochrane Library
Sugar-sweetened beverage taxes: Lessons to date and the future of taxation – PLOS Medicine
Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation
Sugar tax: why health experts want it but politicians and industry are resisting – The Guardian
Commentary on Twitter
Sugar is addictive and keeps you hooked on unhealthy drinks like sodas & energy drinks.
Break the cycle today for a healthier life! https://t.co/M1GQE4136I pic.twitter.com/06aVCYmeK5— World Health Organization (WHO) (@WHO) December 13, 2022
Cohort Study | Association of the triglyceride glucose index as a measure of insulin resistance with mortality and CVD
9 Jan, 2023 | 13:42h | UTCInvited Commentary: The triglyceride glucose index and cardiovascular disease outcomes – The Lancet Health Longevity
RCT | Effect of an intermittent calorie-restricted diet on Type 2 DM remission.
16 Dec, 2022 | 13:43h | UTCEffect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial – The Journal of Clinical Endocrinology & Metabolism (link to abstract – $ for full-text)
Commentaries:
Expert reaction to study looking at intermittent fasting and type 2 diabetes – Science Media Centre
Intermittent Fasting Can Achieve Remission in Type 2 Diabetes – HealthDay
Commentary on Twitter
Can an intermittent fasting (IF) diet reverse Type 2 diabetes?
A small randomized trial says yes, w/ 47% of IF-assigned participants achieving remission for at least 1 year vs 3% of controls (odds ratio of 31; yes, too good to be true)https://t.co/Ths3LrNL8u
Worth further study pic.twitter.com/VwOqMeAAJr— Eric Topol (@EricTopol) December 14, 2022
Guideline | ADA 2023 Standards of Medical Care in Diabetes.
14 Dec, 2022 | 15:59h | UTCGuideline Homepage: ADA 2023 Standards of Medical Care in Diabetes – American Diabetes Association
Introduction: Standards of Medical Care in Diabetes—2023
Summary of Revisions: Standards of Medical Care in Diabetes—2023
- Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023
- Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
- Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
- Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
- Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023
- Glycemic Targets: Standards of Care in Diabetes—2023
- Diabetes Technology: Standards of Care in Diabetes—2023
- Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023
- Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
- Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
- Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
- Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
- Older Adults: Standards of Care in Diabetes—2023
- Children and Adolescents: Standards of Care in Diabetes—2023
- Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023
- Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
- Diabetes Advocacy: Standards of Care in Diabetes—2023
RCT | A remotely delivered self-directed behavioral intervention resulted in little weight loss in adults with obesity.
16 Dec, 2022 | 13:38h | UTCEffect of a Remotely Delivered Self-directed Behavioral Intervention on Body Weight and Physical Health Status Among Adults With Obesity: The D-ELITE Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: The Challenge of Defining the Optimal Lifestyle Weight Loss Intervention for Real-world Settings – JAMA (free for a limited period)
Commentary from the author on Twitter (thread – click for more)
https://twitter.com/KateHoerster/status/1602703023738064897
Consensus Statement | Continuous glucose monitoring and metrics for clinical trials.
15 Dec, 2022 | 13:42h | UTCContinuous glucose monitoring and metrics for clinical trials: an international consensus statement – The Lancet Diabetes & Endocrinology (free registration required)
Commentary on Twitter
Online—Continuous glucose monitoring and metrics for clinical trials: an international consensus statement https://t.co/hrNXB9ycr0 #CGM #diabetes #FREE to read with registration (also FREE) #IDF2022 pic.twitter.com/x40lzAL1by
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) December 7, 2022
RCT | A calorie-unrestricted low-carbohydrate, high-fat diet resulted in short-term weight loss and better glycemic control.
14 Dec, 2022 | 15:08h | UTCEffect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Low-Carbohydrate, High-Fat Diet Beneficial in T2DM in Short Term – HealthDay
Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease – Annals of Internal Medicine
Commentary on Twitter
RCT finds low-carb diet beats low-fat diet for weight loss and glucose control in patients with #type2diabetes over 6-month intervention, but changes not sustained. @AleksanderKrag @Camilla_Dalby @FLASH_OUH: https://t.co/4v58k8KK4x pic.twitter.com/zwgIBDCxCB
— Annals of Int Med (@AnnalsofIM) December 13, 2022
RCT | Small trial suggests butyrate may be effective in reducing pediatric obesity.
14 Dec, 2022 | 14:56h | UTC
Commentary on Twitter
This pilot RCT found 6-month oral butyrate supplementation may be an effective adjunct in treating children with obesity. https://t.co/P4GLdAX7KI #OAResearch
— JAMA Network Open (@JAMANetworkOpen) December 5, 2022
Review | GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with Type 2 Diabetes.
13 Dec, 2022 | 14:29h | UTCGLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes – Circulation (free for a limited period)
Consensus Statement | Management of thyroid eye disease.
12 Dec, 2022 | 12:51h | UTCCommentary: Worldwide Consensus on Thyroid Eye Disease? What Is In a Name? – Thyroid
UEG position paper | Obesity and digestive health.
12 Dec, 2022 | 12:41h | UTCUEG position paper: Obesity and digestive health – UEG Journal


